CABLES2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.829200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.771800E-01
Normal-vs-Stage2
7.481800E-01
Normal-vs-Stage3
1.280420E-01
Normal-vs-Stage4
4.202400E-01
Stage1-vs-Stage2
9.635800E-02
Stage1-vs-Stage3
8.408200E-02
Stage1-vs-Stage4
3.707000E-01
Stage2-vs-Stage3
1.267780E-01
Stage2-vs-Stage4
3.974800E-01
Stage3-vs-Stage4
3.262200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.068600E-01
Normal-vs-AfricanAmerican
8.596600E-01
Normal-vs-Asian
5.578200E-01
Caucasian-vs-AfricanAmerican
9.953000E-01
Caucasian-vs-Asian
4.468600E-01
AfricanAmerican-vs-Asian
6.222000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.729000E-01
Normal-vs-Female
9.540000E-01
Male-vs-Female
6.450600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.913800E-01
Normal-vs-Age(41-60Yrs)
8.555000E-01
Normal-vs-Age(61-80Yrs)
9.147400E-01
Normal-vs-Age(81-100Yrs)
4.176800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.631400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.096600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.479600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.055800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.838400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.354000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.212800E-01
Normal-vs-Daily Drinker
8.165600E-01
Normal-vs-Weekly Drinker
8.806600E-01
Normal-vs-Occasional Drinker
7.617000E-01
Normal-vs-Social Drinker
8.147400E-01
Non Drinker-vs-Daily Drinker
4.139400E-01
Non Drinker-vs-Weekly Drinker
3.818800E-01
Non Drinker-vs-Occasional Drinker
2.713800E-01
Non Drinker-vs-Social Drinker
2.554200E-01
Daily Drinker-vs-Weekly Drinker
8.864400E-01
Daily Drinker-vs-Occasional Drinker
3.804000E-01
Daily Drinker-vs-Social Drinker
4.551000E-01
Weekly Drinker-vs-Occasional Drinker
4.113800E-01
Weekly Drinker-vs-Social Drinker
5.191600E-01
Occasional Drinker-vs-Social Drinker
6.875400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.315800E-01
Normal-vs-Grade 2
7.809600E-01
Normal-vs-Grade 3
9.478800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.134200E-01
Grade 1-vs-Grade 3
9.333900E-02
Grade 1-vs-Grade 4
8.315800E-01
Grade 2-vs-Grade 3
4.471800E-01
Grade 2-vs-Grade 4
7.809600E-01
Grade 3-vs-Grade 4
9.478800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.815000E-01
Normal-vs-NonDiabetic
8.546400E-01
Diabetic-vs-NonDiabetic
8.649200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.436400E-01
Normal-vs-NoPancreatitis
9.019000E-01
Pancreatitis-vs-NoPancreatitis
5.044200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.074000E-01
Normal-vs-N1
9.140600E-01
N0-vs-N1
7.028600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.339800E-01
Normal-vs-TP53-NonMutant
8.769600E-01
TP53-Mutant-vs-TP53-NonMutant
2.324200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
